Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 6, 2003; DOI: 10.1124/jpet.102.046581
0022-3565/03/3053-1212-1221$20.00
JPET 305:1212-1221, 2003
INFLAMMATION AND IMMUNOPHARMACOLOGY
Histamine H4 Receptor Mediates Chemotaxis and Calcium Mobilization of Mast Cells
Claudia L. Hofstra1,
Pragnya J. Desai,
Robin L. Thurmond, and
Wai-Ping Fung-Leung
Johnson and Johnson Pharmaceutical Research and Development LLC, San
Diego, California
The diverse physiological functions of histamine are mediated through
distinct histamine receptors. Mast cells are major producers of histamine, yet
effects of histamine on mast cells are currently unclear. The present study
shows that histamine induces chemotaxis of mouse mast cells, without affecting
mast cell degranulation. Mast cell chemotaxis toward histamine could be
blocked by the dual H3/H4 receptor antagonist
thioperamide, but not by H1 or H2 receptor antagonists.
This chemotactic response is mediated by the H4 receptor, because
chemotaxis toward histamine was absent in mast cells derived from
H4 receptor-deficient mice but was detected in H3
receptor-deficient mast cells. In addition, Northern blot analysis showed the
expression of H4 but not H3 receptors on mast cells.
Activation of H4 receptors by histamine resulted in calcium
mobilization from intracellular calcium stores. Both G
i/o proteins and
phospholipase C (PLC) are involved in histamine-induced calcium mobilization
and chemotaxis in mast cells, because these responses were completely
inhibited by pertussis toxin and PLC inhibitor
1-[6-[[17
-3-methoxyestra-1,3,5
(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122). In
summary, histamine was shown to mediate signaling and chemotaxis of mast cells
via the H4 receptor. This mechanism might be responsible for mast
cell accumulation in allergic tissues.
Received November 5, 2002;
accepted February 25, 2003.
Address correspondence to: Dr. Wai-Ping Fung-Leung, Johnson and Johnson
Pharmaceutical Research and Development, 3210 Merryfield Row, San Diego, CA
92121. E-mail:
wleung{at}prdus.jnj.com
This article has been cited by other articles:

|
 |

|
 |
 
M. C. Leite-de-Moraes, S. Diem, M.-L. Michel, H. Ohtsu, R. L. Thurmond, E. Schneider, and M. Dy
Cutting Edge: Histamine Receptor H4 Activation Positively Regulates In Vivo IL-4 and IFN-{gamma} Production by Invariant NKT Cells
J. Immunol.,
February 1, 2009;
182(3):
1233 - 1236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sakanaka, S. Tanaka, Y. Sugimoto, and A. Ichikawa
Essential role of EP3 subtype in prostaglandin E2-induced adhesion of mouse cultured and peritoneal mast cells to the Arg-Gly-Asp-enriched matrix
Am J Physiol Cell Physiol,
November 1, 2008;
295(5):
C1427 - C1433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. D. Lim, A. Jongejan, R. A. Bakker, E. Haaksma, I. J. P. de Esch, and R. Leurs
Phenylalanine 169 in the Second Extracellular Loop of the Human Histamine H4 Receptor Is Responsible for the Difference in Agonist Binding between Human and Mouse H4 Receptors
J. Pharmacol. Exp. Ther.,
October 1, 2008;
327(1):
88 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Sutton, A. Zhao, K. B. Madden, J. E. Elfrey, B. A. Tuft, C. A. Sullivan, J. F. Urban Jr., and T. Shea-Donohue
Anti-Inflammatory Mechanisms of Enteric Heligmosomoides polygyrus Infection against Trinitrobenzene Sulfonic Acid-Induced Colitis in a Murine Model
Infect. Immun.,
October 1, 2008;
76(10):
4772 - 4782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. Haas, O. A. Sergeeva, and O. Selbach
Histamine in the Nervous System
Physiol Rev,
July 1, 2008;
88(3):
1183 - 1241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Beghdadi, A. Porcherie, B. S. Schneider, D. Dubayle, R. Peronet, M. Huerre, T. Watanabe, H. Ohtsu, J. Louis, and S. Mecheri
Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease
J. Exp. Med.,
February 18, 2008;
205(2):
395 - 408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kanda and S. Watanabe
Histamine enhances the production of human -defensin-2 in human keratinocytes
Am J Physiol Cell Physiol,
December 1, 2007;
293(6):
C1916 - C1923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Morgan, B. McAllister, L. Cross, D. S. Green, H. Kornfeld, D. M. Center, and W. W. Cruikshank
Histamine 4 Receptor Activation Induces Recruitment of FoxP3+ T Cells and Inhibits Allergic Asthma in a Murine Model
J. Immunol.,
June 15, 2007;
178(12):
8081 - 8089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Youssef, M. Schuyler, L. Gilmartin, G. Pickett, J. D. J. Bard, C. A. Tarleton, T. Archibeque, C. Qualls, B. S. Wilson, and J. M. Oliver
Histamine Release from the Basophils of Control and Asthmatic Subjects and a Comparison of Gene Expression between "Releaser" and "Nonreleaser" Basophils
J. Immunol.,
April 1, 2007;
178(7):
4584 - 4594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kim, A. Ogai, S. Nakatani, K. Hashimura, H. Kanzaki, K. Komamura, M. Asakura, H. Asanuma, S. Kitamura, H. Tomoike, et al.
Impact of Blockade of Histamine H2 Receptors on Chronic Heart Failure Revealed by Retrospective and Prospective Randomized Studies
J. Am. Coll. Cardiol.,
October 3, 2006;
48(7):
1378 - 1384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. van Rijn, P. L. Chazot, F. C. Shenton, K. Sansuk, R. A. Bakker, and R. Leurs
Oligomerization of Recombinant and Endogenously Expressed Human Histamine H4 Receptors
Mol. Pharmacol.,
August 1, 2006;
70(2):
604 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Dunford, N. O'Donnell, J. P. Riley, K. N. Williams, L. Karlsson, and R. L. Thurmond
The Histamine H4 Receptor Mediates Allergic Airway Inflammation by Regulating the Activation of CD4+ T Cells.
J. Immunol.,
June 1, 2006;
176(11):
7062 - 7070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. D. Lim, R. M. van Rijn, P. Ling, R. A. Bakker, R. L. Thurmond, and R. Leurs
Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor Agonist
J. Pharmacol. Exp. Ther.,
September 1, 2005;
314(3):
1310 - 1321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Schneider, F. Machavoine, J.-M. Pleau, A.-F. Bertron, R. L. Thurmond, H. Ohtsu, T. Watanabe, A. H. Schinkel, and M. Dy
Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels
J. Exp. Med.,
August 1, 2005;
202(3):
387 - 393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gutzmer, C. Diestel, S. Mommert, B. Kother, H. Stark, M. Wittmann, and T. Werfel
Histamine H4 Receptor Stimulation Suppresses IL-12p70 Production and Mediates Chemotaxis in Human Monocyte-Derived Dendritic Cells
J. Immunol.,
May 1, 2005;
174(9):
5224 - 5232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nakayama, Y. Kato, K. Hieshima, D. Nagakubo, Y. Kunori, T. Fujisawa, and O. Yoshie
Liver-Expressed Chemokine/CC Chemokine Ligand 16 Attracts Eosinophils by Interacting with Histamine H4 Receptor
J. Immunol.,
August 1, 2004;
173(3):
2078 - 2083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Thurmond, P. J. Desai, P. J. Dunford, W.-P. Fung-Leung, C. L. Hofstra, W. Jiang, S. Nguyen, J. P. Riley, S. Sun, K. N. Williams, et al.
A Potent and Selective Histamine H4 Receptor Antagonist with Anti-Inflammatory Properties
J. Pharmacol. Exp. Ther.,
April 1, 2004;
309(1):
404 - 413.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Takeshita, K. Sakai, K. B. Bacon, and F. Gantner
Critical Role of Histamine H4 Receptor in Leukotriene B4 Production and Mast Cell-Dependent Neutrophil Recruitment Induced by Zymosan in Vivo
J. Pharmacol. Exp. Ther.,
December 1, 2003;
307(3):
1072 - 1078.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.